Anticoagulation Therapy

The available parenteral and oral anticoagulants have a large clinical use. Understanding biochemistry of anticoagulants may help to improve therapeutic strategies. Resistance to vitamin K antagonist drugs might be a problem for rodent populations. Patients who have thrombogenic risk factors should...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
פורמט: Online
שפה:אנגלית
יצא לאור: IntechOpen 2021
נושאים:
גישה מקוונת:ONIX_20210420_9789535126676_2278
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
_version_ 1869515879225491456
collection Directory of Open Access Books
description The available parenteral and oral anticoagulants have a large clinical use. Understanding biochemistry of anticoagulants may help to improve therapeutic strategies. Resistance to vitamin K antagonist drugs might be a problem for rodent populations. Patients who have thrombogenic risk factors should be anticoagulated. The need for cardiac implantable electronic devices is increasing, and there is a substantial number of patients who are on oral anticoagulant therapy. Prothrombin complex concentrate and other plasma concentrates are useful to deal with over-coagulated situations. The efficacy and safety of non-vitamin K antagonist oral anticoagulants have been proven in large phase III trials. The real-world data suggest even better outcomes with these agents compared to vitamin K antagonists.
format Online
id doab-20.500.12854ir-66919
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher IntechOpen
publisherStr IntechOpen
record_format ojs
spelling doab-20.500.12854ir-669192024-04-01T14:14:50Z Anticoagulation Therapy Basaran, Ozcan Biteker, Murat Pharmacology thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology The available parenteral and oral anticoagulants have a large clinical use. Understanding biochemistry of anticoagulants may help to improve therapeutic strategies. Resistance to vitamin K antagonist drugs might be a problem for rodent populations. Patients who have thrombogenic risk factors should be anticoagulated. The need for cardiac implantable electronic devices is increasing, and there is a substantial number of patients who are on oral anticoagulant therapy. Prothrombin complex concentrate and other plasma concentrates are useful to deal with over-coagulated situations. The efficacy and safety of non-vitamin K antagonist oral anticoagulants have been proven in large phase III trials. The real-world data suggest even better outcomes with these agents compared to vitamin K antagonists. 2021-04-20T15:57:25Z 2021-04-20T15:57:25Z 2016 book ONIX_20210420_9789535126676_2278 9789535126676 9789535126669 9789535173090 https://directory.doabooks.org/handle/20.500.12854/66919 eng image/jpeg n/a https://www.intechopen.com/books https://mts.intechopen.com/storage/books/5173/authors_book/authors_book.pdf IntechOpen IntechOpen 10.5772/61447 10.5772/61447 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 9789535126676 9789535126669 9789535173090 IntechOpen 150 open access
spellingShingle Pharmacology
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
Anticoagulation Therapy
title Anticoagulation Therapy
title_full Anticoagulation Therapy
title_fullStr Anticoagulation Therapy
title_full_unstemmed Anticoagulation Therapy
title_short Anticoagulation Therapy
title_sort anticoagulation therapy
topic Pharmacology
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
topic_facet Pharmacology
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
url ONIX_20210420_9789535126676_2278